MI HR0182

Urges Congress to enact legislation permitting Medicare to negotiate prescription drug prices directly with pharmaceutical manufacturers.

Cites that approximately 76 percent of older adults believe prescription drug costs are unreasonable, with nearly 9 out of 10 adults over age 65 taking at least one prescription medication.

Notes federal law currently prohibits the Secretary of Health and Human Services from negotiating drug prices or setting payment structures for Medicare Part D, while private insurers negotiate directly with drug companies.

References polling showing 80 percent bipartisan public support for allowing the federal government to negotiate lower prescription drug prices for Medicare beneficiaries.

Directs that copies of the resolution be transmitted to the President of the Senate, Speaker of the House, and Michigan's congressional delegation.